2022 | Synthekine

Fierce Biotech names Synthekine as one of its “Fierce 15” Biotech Companies of 2022

September 12, 2022/in 2022, news/by David Anderson

September 12, 2022

Synthekine Announces Multiple Poster Presentations Showcasing Its Three Distinct Cytokine Engineering Platforms at American Association for Cancer Research (AACR) 2022 Annual Meeting

April 7, 2022/in 2022, news/by David Anderson

April 7, 2022

Synthekine Doses First Patient in Phase 1 Clinical Trial of IL-2 Partial Agonist, STK-012, for Treatment of Solid Tumors

February 3, 2022/in 2022, news/by David Anderson

February 3, 2022